Macegoniuk Katarzyna, Grela Ewa, Biernat Monika, Psurski Mateusz, Gościniak Grażyna, Dziełak Anna, Mucha Artur, Wietrzyk Joanna, Berlicki Łukasz, Grabowiecka Agnieszka
Wrocław University of Technology, Faculty of Chemistry, Department of Bioorganic Chemistry, Wrocław, Poland.
Medical University of Wrocław, Department of Microbiology, Wrocław, Poland.
PLoS One. 2017 Aug 9;12(8):e0182437. doi: 10.1371/journal.pone.0182437. eCollection 2017.
Urease is an important virulence factor from Helicobacter pylori that enables bacterial colonization of human gastric mucosa. Specific inhibition of urease activity can be regarded as a promising adjuvant strategy for eradication of this pathogen. A group of organophosphorus inhibitors of urease, namely, aminophosphinic acid and aminophosphonic acid derivatives, were evaluated in vitro against H. pylori urease. The kinetic characteristics of recombinant enzyme activity demonstrated a competitive reversible mode of inhibition with Ki values ranging from 0.294 to 878 μM. N-n-Hexylaminomethyl-P-aminomethylphosphinic acid and N-methylaminomethyl-P-hydroxymethylphosphinic acid were the most effective inhibitors (Ki = 0.294 μM and 1.032 μM, respectively, compared to Ki = 23 μM for the established urease inhibitor acetohydroxamic acid). The biological relevance of the inhibitors was verified in vitro against a ureolytically active Escherichia coli Rosetta host that expressed H. pylori urease and against a reference strain, H. pylori J99 (CagA+/VacA+). The majority of the studied compounds exhibited urease-inhibiting activity in these whole-cell systems. Bis(N-methylaminomethyl)phosphinic acid was found to be the most effective inhibitor in the susceptibility profile studies of H. pylori J99. The cytotoxicity of nine structurally varied inhibitors was evaluated against four normal human cell lines and was found to be negligible.
脲酶是幽门螺杆菌的一种重要毒力因子,可使人胃黏膜发生细菌定植。特异性抑制脲酶活性可被视为根除该病原体的一种有前景的辅助策略。对一组脲酶的有机磷抑制剂,即氨基次膦酸和氨基膦酸衍生物,进行了体外抗幽门螺杆菌脲酶的评估。重组酶活性的动力学特征显示为竞争性可逆抑制模式,Ki值范围为0.294至878 μM。N-正己基氨基甲基-P-氨基甲基次膦酸和N-甲基氨基甲基-P-羟甲基次膦酸是最有效的抑制剂(Ki分别为0.294 μM和1.032 μM,而公认的脲酶抑制剂乙酰氧肟酸的Ki为23 μM)。在体外对表达幽门螺杆菌脲酶的具有脲分解活性的大肠杆菌Rosetta宿主以及参考菌株幽门螺杆菌J99(CagA+/VacA+)验证了这些抑制剂的生物学相关性。在这些全细胞系统中,大多数研究化合物都表现出脲酶抑制活性。在幽门螺杆菌J99的药敏试验研究中,发现双(N-甲基氨基甲基)次膦酸是最有效的抑制剂。评估了9种结构各异的抑制剂对4种正常人细胞系的细胞毒性,发现其可忽略不计。